Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/30/1996 | CA2205500A1 Methods and apparatus for making liposomes containing hydrophobic drugs |
05/30/1996 | CA2205486A1 Polynucleotide compositions |
05/30/1996 | CA2204639A1 Antibacterial dibenzimidazole derivatives |
05/30/1996 | CA2204519A1 Percutaneously absorbable patch |
05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
05/30/1996 | CA2203921A1 Hypolipidemic benzothiazepines |
05/30/1996 | CA2202265A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
05/30/1996 | CA2201886A1 Morphine and codeine derivatives for use in therapy |
05/30/1996 | CA2201735A1 A new physically stable solid form of a fluoroquinolone |
05/30/1996 | CA2181364A1 Preparation for percutaneous absorption |
05/29/1996 | EP0713875A1 Sulfonamides |
05/29/1996 | EP0713870A1 Novel fused indan derivative and pharmaceutically acceptable salt thereof |
05/29/1996 | EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them |
05/29/1996 | EP0713706A2 Lipoprotein (a) lowering agent, cholesterol lowering agent and medicaments comprising these agents respectively |
05/29/1996 | EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors |
05/29/1996 | EP0713703A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders |
05/29/1996 | EP0713702A1 Anxiolytic agent |
05/29/1996 | EP0713701A1 2-Bromomelatonin in the therapy of sleep disorders |
05/29/1996 | EP0713700A1 mUse of lauric acid or a monogryceride of a C8-C16 fatty acid for inhibiting Helicobacter |
05/29/1996 | EP0713699A2 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
05/29/1996 | EP0713698A2 Medical use of atypical beta-adrenoceptor agonists |
05/29/1996 | EP0713697A1 Analgesic anti-inflammatory adhesive preparations |
05/29/1996 | EP0713696A1 Topical application product containing a lipase and a precursor of hydroxyacid |
05/29/1996 | EP0713653A1 Fortified fruit juice |
05/29/1996 | EP0713527A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
05/29/1996 | EP0713487A1 Novel quinolone carboxylic acid derivatives |
05/29/1996 | EP0713484A1 Inhibitors of biogenic amine transporters |
05/29/1996 | EP0713483A1 Amidine derivatives with nitric oxide synthetase activities |
05/29/1996 | EP0713394A1 Method of preventing neutrophil mediated connective tissue damage |
05/29/1996 | EP0713393A1 Estrogenic compounds as anti-mitotic agents |
05/29/1996 | EP0713392A1 Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases |
05/29/1996 | EP0713391A1 Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes |
05/29/1996 | EP0713390A1 Gelatin capsules containing a highly concentrated acetaminophen solution |
05/29/1996 | EP0713386A1 Spray formulation having a cooling effect |
05/29/1996 | EP0713383A1 Sunscreen agents |
05/29/1996 | EP0697862A4 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders |
05/29/1996 | EP0680329A4 Prevention and treatment of myocardial failure. |
05/29/1996 | EP0673545A4 Process and apparatus for etching semiconductor wafers. |
05/29/1996 | EP0641346B1 7'-amino-naphthazarin antibiotic derivatives |
05/29/1996 | EP0639179B1 23-oxa derivatives of d-series vitamins, method of preparing them, pharmaceutical preparations containing them, and the use of such preparations as drugs |
05/29/1996 | EP0625899B1 Liposomal itraconazole formulations |
05/29/1996 | EP0589037B1 Indian derivative and thromboxane antagonist containing the same |
05/29/1996 | EP0575481B1 Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
05/29/1996 | EP0527748B1 Use of prostaglandin F3alpha as an ocular hypotensive agent |
05/29/1996 | EP0521967B1 New use of bambuterol |
05/29/1996 | EP0506778B1 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
05/29/1996 | EP0506658B1 Compositions and method for treating painful, inflammatory or allergic disorders |
05/29/1996 | EP0490944B1 Transmucosal dosage form |
05/29/1996 | EP0477315B1 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
05/29/1996 | EP0346431B1 Onset-hastened/enhanced analgesia using s(+) ketoprofen |
05/29/1996 | EP0233255B1 Conversion of cephalosporin hydrohalide salt to alkali metal salt |
05/29/1996 | CN1123549A Crystalline benzathine salt of cefonicid and its preparation |
05/29/1996 | CN1123548A Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
05/29/1996 | CN1123547A Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
05/29/1996 | CN1123546A 4-arylisoindole analgesics |
05/29/1996 | CN1123545A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells |
05/29/1996 | CN1123544A Optically active 3-(1-(alkylamino)) alkyl pyrrolidines |
05/29/1996 | CN1123525A Tylosin containing sustained release veterinary compositions |
05/29/1996 | CN1123524A Compositions in the form of solid solutions |
05/29/1996 | CN1123523A Methods of using hesperetin for sebum control and treatment of ACNE |
05/29/1996 | CN1123282A Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives |
05/29/1996 | CN1123280A Novel pyrrolocarbazoles |
05/29/1996 | CN1123279A Azithmycin water-soluble salt, injection thereof and their usage |
05/29/1996 | CN1123276A Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
05/29/1996 | CN1123275A Substituted chinolin derivative, preparation and application of same |
05/29/1996 | CN1123272A Ysnthetic excitatory amino acids |
05/29/1996 | CN1123269A Method for preparation of ethyl tert-butyl ether and prdouct thereof and application thereof |
05/29/1996 | CN1123145A Medicinal compound for curing women's involutional syndrome |
05/29/1996 | CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication |
05/29/1996 | CN1123143A Injection for curing psoriasic |
05/29/1996 | CN1123142A Fluoxetine pahrmaceutical formulations |
05/29/1996 | CN1123141A Aerosol preparation and preparation method thereof |
05/29/1996 | CN1123115A Phosphatide drink and preparation method thereof |
05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
05/29/1996 | CN1031879C Process for preparing ATP analogues |
05/29/1996 | CN1031878C Process for preparing mono and bis alkylamino anthracyclines |
05/29/1996 | CN1031862C Process for preparation of pharmaceutical composition |
05/29/1996 | CN1031859C Air treatment plant for foodstuffs |
05/29/1996 | CA2163840A1 Potentiation of drug response |
05/28/1996 | US5521315 Olefin substituted long chain compounds |
05/28/1996 | US5521314 N-(3-hydroxy)-4-piperidinyl) (Dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
05/28/1996 | US5521310 Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives |
05/28/1996 | US5521308 Process for the preparation of crystalline TACA |
05/28/1996 | US5521307 Methods and compounds for the preparation of carbacephems |
05/28/1996 | US5521303 Sulfation of cotton linters with sulfur trioxide/dmf complex and filtration |
05/28/1996 | US5521223 Methods of using lysophosphatidic acids for regulating skin wrinkles |
05/28/1996 | US5521221 Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol |
05/28/1996 | US5521220 Treating inflammatory and central nervous system disorders |
05/28/1996 | US5521219 Treatment of aids |
05/28/1996 | US5521216 Treating complications of diabetes |
05/28/1996 | US5521215 Treatment of nervous system injuries |
05/28/1996 | US5521214 2-phenyl-3-aroylbenzothiophenes |
05/28/1996 | US5521213 Nonsteroid antiinflammatory agents |
05/28/1996 | US5521210 Stabilization of intraocular lenses after surgery |
05/28/1996 | US5521209 N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof |
05/28/1996 | US5521208 Nonracemic chiral spirofluorenehydantoins, antidiabetic agents |
05/28/1996 | US5521207 Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
05/28/1996 | US5521206 Hypotensive agents, treatment of atherosclerosis |
05/28/1996 | US5521204 Benzimidazole anthelmintic agents |